Data Snapshot: Oct 05, 2026
<$50K

Sep-2026

Sales

Decline

Trend

6-Month

19

Product Count

SKUs

$16.77

Avg Price

-33.9%

YoY Sales Change

-4.1%

YoY Price Change

Chronic Health presents itself as a brand focused on offering cannabis-related products for the alleviation of several persistent and severe health conditions such as Crohn's disease, chronic pain, and Multiple Sclerosis. Despite the fact that the FDA has yet to approve the cannabis plant for medicinal use, there is a growing trend towards recognizing its potential benefits, especially for those with chronic ailments who may find extended relief beneficial in everyday environments like the workplace. However, given the concerns regarding limited research on long-term impacts of "medical marijuana" use, Chronic Health operates amidst a duality of growing acceptance and ongoing scientific scrutiny.
Chronic Health

Where to Buy

Chronic Health is stocked at 39 licensed dispensaries across Arizona, with the deepest coverage in Phoenix, Mesa, Tucson, Kingman, and Buckeye. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.

https://headsetstorage.blob.core.windows.net/brand-stores/10802.json?v=20261004
Chronic Health Sales

Market Insights Snapshot

Chronic Health Historical Sales by Category

In September 2026, Chronic Health concentrated 63.22% of sales in Topical, down 27.97% year over year and 27.48% month over month, while Tincture & Sublingual held 36.78% with steeper drops of 42.16% YoY and 25.40% MoM; this mix sits alongside a brand-level YoY decline of 33.93% and a 4.13% YoY price decrease. Within Arizona Topical, the brand ranked 4, implying category leadership inside the portfolio but pressure on absolute volume as both core categories contracted double-digits simultaneously.

The sharper YoY contraction in Tincture & Sublingual at 42.16% versus Topical’s 27.97%, combined with the rank of 4 in Arizona Topical and a 27.48% MoM slide in Topical against 25.40% in Tincture & Sublingual, indicates a defensive tilt toward Topical where relative standing is higher but demand is softening at a comparable monthly pace. The pattern implies that maintaining Topical share while overall sales fell 33.93% YoY and average prices dropped 4.13% could anchor short-term positioning, but recovery likely hinges on stabilizing Tincture & Sublingual where mix weight is 36.78% yet decline rates outpace the portfolio.

Sep-2026 Rank
Tincture & Sublingual
Topical
3
4
Category
Share of Sales
Avg Item Price
YoY %
MoM %
Topical
63.2%
$21.62
-28.0%
-27.5%
Tincture & Sublingual
36.8%
$12.09
-42.2%
-25.4%
Chronic Health

Competitive Landscape

Chronic Health sits at rank #4 in AZ Topical for September 2026, sliding 2 positions year over year from #2, and down 2 ranks from June 2026’s #2, while remaining below its peak at #1 in March 2025; meanwhile, Drip Oils + Extracts holds #1 with a 49.7% YoY sales increase and Gramz climbed to #2 from #7 YoY with 97.3% growth, outpacing Chronic Health’s rank trajectory, as iLava moved to #3 despite a -8.9% YoY sales change and Tru Infusion fell to #5 with a -46.3% YoY decline; the pattern implies Chronic Health’s slide from #2 to #4 is driven less by its own absolute performance and more by accelerated gains from rising competitors at the top.

Chronic Health market ranking for AZ Topical

Chronic Health

Notable Products

CBD/THC 1:1 Glycerin Tincture (100mg CBD, 100mg THC, 1oz) posted the steepest decline at -54.2% MoM and slid to rank 3, while the CBD/THC 1:1 Sleep Well Tincture (100mg CBD, 100mg THC, 1oz) fell -12.0% MoM at rank 2. In contrast, CBD/THC 1:1 Pain Relief Ointment (50mg CBD, 50mg THC) surged +74.5% MoM at rank 6, even as the larger 175mg and 350mg Topical formats dropped -46.1% and -26.0% MoM at ranks 5 and 8. Four of the top ten are Topical SKUs, and the Indica THC Glycerin Tincture (100mg THC, 1oz) rose +7.6% MoM to rank 1 with $3,477 in sales, pointing to shopper trade-down into lower-dosage topicals and THC-forward tinctures over 1:1 formats.

Product
Category
May-2026
Jun-2026
Jul-2026
Aug-2026
Sep-2026
MoM %
Indica THC Glycerin Tincture (100mg THC, 1oz)
Tincture & Sublingual
1
1
1
3
1
+7.6%
CBD/THC 1:1 Sleep Well Tincture (100mg CBD, 100mg THC, 1oz)
Tincture & Sublingual
2
2
2
2
2
-12.0%
CBD/THC 1:1 Glycerin Tincture (100mg CBD, 100mg THC, 1oz)
Tincture & Sublingual
4
3
4
1
3
-54.2%
CBD/THC 1:1 Pain Relief Ointment (350mg CBD, 350mg THC, 4oz)
Topical
5
5
5
5
4
-11.9%
CBD/THC 1:1 Pain Relief Ointment (175mg CBD, 175mg THC, 2oz)
Topical
3
4
3
4
5
-46.1%
CBD/THC 1:1 Pain Relief Ointment (50mg CBD, 50mg THC)
Topical
8
9
9
10
6
+74.5%
Pain Relief Ointment (90mg)
Topical
7
7
6
7
6
-2.2%
THC Pain Relief Lotion (100mg)
Topical
6
6
7
7
7
-5.0%
CBD High Ointment (350mg CBD, 2oz)
Topical
10
10
9
6
8
-26.0%
CBD/THC 1:1 Pain Relief Roll-On (50mg CBD, 50mg THC)
Topical
>10
>10
9
8
9
-24.1%
View product & sales data

Top Selling Cannabis Brands

Simple, transparent pricing that grows with you.
Research the top cannabis brands across markets in the US and Canada.

Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.

Header image
User rating
start Today
Stay ahead of the competition with real-time market data insights.

Discover How Your Brand Stacks Up in the Market